Literature DB >> 10771971

Care mapping: a common sense approach.

A Schwoebel1.   

Abstract

Because of trends in the health care environment, hospitals are searching for ways to continuously improve the quality of care and to decrease the costs of care. One approach that is gaining widespread recognition throughout the United States is the use of case management and practice guidelines such as critical paths, CareMaps, and in the neonatal field, NeoMaps. The NeoMap is a clinical tool which delineates practice guidelines for each discipline that provide care to a specific infant population. It reduces variation in clinical process and thereby has been shown to improve the quality of infant care. When practice guidelines are linked to both health and economic outcomes, they have significant impact on health care costs. In this paper, case management and the development of the NeoMap will be described in relation to the Intensive Care Nursery (ICN) at Pennsylvania Hospital.

Entities:  

Mesh:

Year:  1998        PMID: 10771971     DOI: 10.1007/bf02752302

Source DB:  PubMed          Journal:  Indian J Pediatr        ISSN: 0019-5456            Impact factor:   1.967


  5 in total

1.  The critical path: an evaluation of the applicability of nursing case management in the NICU.

Authors:  J R Neidig; M E Megel; K M Koehler
Journal:  Neonatal Netw       Date:  1992-08

2.  Case management: a bottom-line care delivery model. Part 1: The concept.

Authors:  G S Olivas; V Del Togno-Armanasco; J R Erickson; S Harter
Journal:  J Nurs Adm       Date:  1989-11       Impact factor: 1.737

3.  Critical pathways: what they are and what they are not.

Authors:  E Greenfield
Journal:  J Burn Care Rehabil       Date:  1995 Mar-Apr

4.  Nursing case management in the neonatal intensive care unit, Part 2: Developing critical pathways.

Authors:  A P Elizondo
Journal:  Neonatal Netw       Date:  1995-02

5.  Nursing case management. Resolving the DRG paradox.

Authors:  K Zander
Journal:  Nurs Clin North Am       Date:  1988-09       Impact factor: 1.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.